Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pathogenesis(pgns) -- Ignore unavailable to you. Want to Upgrade?

To: Jason Urquhart who wrote (101)	7/30/1998 5:34:00 PM
From: Anthony Wong	Respond to of 228

Pathogenesis Corp. Reiterated 'Buy' at Prudential Bloomberg News July 29, 1998, 6:39 a.m. PT Princeton, New Jersey, July 29 (Bloomberg Data) -- Pathogenesis Corp. (PGNS US) was reiterated ''buy'' by analyst David Lippman at Prudential Securities. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

To: Jason Urquhart who wrote (101)	7/30/1998 5:38:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 228

Jason, I can only attribute it to profit-taking. At this late stage of the bull market, I expect many people would like to be in liquid, big-cap names. There's a WSJ article (posted today at the Pfizer thread) that explains this very well. You may wish to read it. Message 5357767 Regards. Anthony